Our projects

Building research oversight capacity in Côte d’IvoireThe CECABI II project is developing the capacity of research ethics bodies in Côte d’Ivoire and enhancing coordination with its national...

Building regulatory capacity in West AfricaThe ECOWAS-RegECs project is helping to build regulatory and ethics capacity by simulating scientific advice and review of Lassa fever vaccine...

Strengthening clinical trial oversight in East AfricaThe RER-CTO project is strengthening clinical trial oversight capacity and harmonising regulatory processes in Ethiopia and Tanzania.

Advancing test-and-treat strategies for vivax malariaThe PvSeroRDT project is exploring whether a new diagnostic test for Plasmodium vivax could underpin a test-and-treat strategy for this...

Enhancing detection of tuberculosis drug resistanceThe R2D2-xDRTB project is creating a platform to simultaneously evaluate multiple tools for detecting resistance to commonly used TB drugs.

Simplifying malaria treatmentThe WANECAM 3 project is advancing novel non-artemisinin drug combinations as potential innovative single-dose treatments for malaria.

Enhancing clinical research during outbreaksThe ACT-PREP project aims to strengthen capacity for conducting clinical trials in sub-Saharan Africa, with a particular focus on research during...

Improving treatment of cutaneous leishmaniasisThe MAMS4CL project is establishing a clinical trial platform to test improved treatments for cutaneous leishmaniasis, a parasitic disease that...

Advancing modelling capacity to control emerging and re-emerging infectious diseasesThe TIMERA project is strengthening national capacities to use modelling to address the challenges posed...

Factors affecting susceptibility to and severity of mpoxThe DECIPHER-MPOX project is identifying host- and virus-related factors responsible for susceptibility to and the severity of mpox...

Widening genomic surveillance in Southern and Eastern AfricaThe GenPath Africa project is expanding existing genomic surveillance infrastructure to capture information on drug-resistant...

Advancing malaria treatments for pregnant womenAdditional Global Health EDCTP3 funding is completing the evaluation of a new antimalarial treatment for pregnant women.

Preventing the return of tuberculosis The RECENT-TB project is exploring whether a course of preventive antibiotics after TB treatment can prevent disease recurrence and how to target those...

Building ‘One Health’ surveillance capacityThe PHM Hub project is strengthening epidemiology and disease-modelling capacity in West and Central Africa, with a particular focus on the human...

Mitigating the risk of antimalarial resistanceThe MARC-SE Africa project is enabling key countries in Africa to track and respond to rising rates of resistance to antimalarial drugs.

Community-based care for vulnerable children after hospital dischargeThe SDx project is assessing whether digital tools can enable community health workers to maintain contact with...

Malaria treatment in early pregnancyThe SAFIRE project is establishing an innovative adaptive clinical trial platform to evaluate antimalarial treatments for women in the first trimester of...

BACKGROUND: Diarrhoea is an important cause of morbidity and mortality in children under 5, especially in SSA. WHO guidelines do not recommend antibiotics for acute watery diarrhoea, while...

Building genomic surveillance capacity in EthiopiaThe EpiGen Ethiopia project is bringing together multiple partners to strengthen the country’s capacity to detect and track known and...